Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Is ‘One to Watch’
FDA-approved LYMPHIR(TM) provides commercial-stage exposure to the oncology market. LYMPHIR(TM) generated $5.6 million in net revenue during the first six…
NewsRoom Articles
Silynxcom Ltd. (NYSE American: SYNX) Grows World Sales In a Rapidly Changing World, Fulfilling Increased Needs for Advanced Communication Headset System Technology
Silynx, producer of field-tested, certified, and combat-proven in-ear tactical communication headset systems, offers clear communication and situational awareness, along with…
India’s Medical-Device Market Surge Seen as Major Growth Opportunity for SS Innovations International Inc. (NASDAQ: SSII)
India’s medical-device market is projected to grow from $15.2 billion in 2025 to $50.1 billion by 2030, with the possible…
The Interception Gap: Directed Energy Solved Cost of Shooting Down Drones, Exposed a Harder Problem Underneath
NetworkNewsWire Editorial Coverage: For most of the past decade, counter-drone defense was framed as a capability question. It has quietly…
Nano-X Imaging Ltd. (NASDAQ: NNOX) Is ‘One to Watch’
The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform…
MindWave Innovations Inc. (NYSE American: APUS) Is Helping Corporations Hold, Manage, and Generate Risk-Aware Yield on Bitcoin Reserves
MindWave Innovations is developing institutional-grade digital asset infrastructure designed to help corporations and institutions hold, manage and generate yield from…
Frontieras North America Inc. Advances a Low-Sulfur Industrial Carbon That Heavy Industry Is Already Looking For
The challenge for steel and other heavy industries is not finding carbon; it is finding carbon that performs reliably without…
From Evaluation to Deployment: SPARC AI Inc.’s (CSE: SPAI) (OTCQB: SPAIF) Push into U.S. Public Safety with GPS-Independent Drone Technology
Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI is expanding…
VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase
Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct…
Frontieras North America Inc. Positions Domestic Coal as America’s Answer to Energy Supply Disruption
The United States sits on a significant coal resource base. FASForm produces six commercial outputs from a single coal input:…